Daniel Seibert is the new CFO of Raumedic AG

04/25/2019

Helmbrechts – Daniel Seibert was appointed as Chief Financial Officer to the Executive Board of Raumedic AG, Helmbrechts, effective April 1. The 50-year-old succeeds Bernhard Kernen, who left the medical technology company in March.

Seibert boasts a great wealth of experience gained at prestigious large companies and then over the course of 14 years as CFO at medium-sized enterprises. The graduate in business administration has worked in different and in some cases very dynamic industries, including spells in the biotechnology and medical technology sector. His previous post was that of Chief Financial Officer at a listed system house for high-tech surfaces and components.

Daniel Seibert is in charge of Finance and Organization at Raumedic. That includes the departments of Accounting, Controlling, Purchasing, IT, Customer Service and Requirements Planning, as well as the company’s Legal Department. “Medical technology is very exciting. It offers a sphere of work that is very meaningful in the truest sense of the word, since its clear mission is to enhance healthcare and quality of life” is how the new CFO at Raumedic explains his return to medical technology, adding: “I also see great growth potential for the company and would like to do my bit in helping it tap that.”

Stefan Seuferling, the company’s Chairman of the Executive Board, is delighted to have acquired an experienced financial expert of Daniel Seibert’s caliber. “We warmly welcome Mr. Seibert to the Executive Board and wish him every success in his new environment. His in-depth know-how will help us control important processes, and so the further development of Raumedic, even better.”

The new CFO of Raumedic Daniel Seibert aims to do all he can to help the company grow.